MTOR and cancer: By this logic, given that PC3 genes were enriched in AMPK and mTOR signaling pathways (Figure S3C), it is possible that perturbed AMPK and mTOR signaling do not strongly underlie metabolic shifts towards increased aerobic glycolysis in highly glycolytic cancers.